Premium
Detection of CD133, Bmi‐1, and ABCG2 in ameloblastic tumors
Author(s) -
Kumamoto Hiroyuki,
Ohki Kousuke
Publication year - 2010
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/j.1600-0714.2009.00807.x
Subject(s) - pathology , abcg2 , immunohistochemistry , carcinogenesis , ameloblastoma , biology , stem cell , odontogenic tumor , adamantinoma , cancer , medicine , odontogenic , anatomy , atp binding cassette transporter , maxilla , biochemistry , genetics , transporter , gene
J Oral Pathol Med (2010) 39 : 87–93 Background: To investigate the roles of stem cell‐related molecules in oncogenesis and cytodifferentiation of odontogenic tumors, expression of CD133, Bmi‐1, and ATP‐binding cassette subfamily G member 2 (ABCG2) was analyzed in ameloblastic tumors as well as in tooth germs. Methods: Tissue specimens of 12 tooth germs, 47 ameloblastomas, and six malignant ameloblastic tumors were examined using reverse transcriptase‐polymerase chain reaction (RT‐PCR) and immunohistochemistry to determine the expression of CD133, Bmi‐1, and ABCG2. Results: mRNA expression of CD133, Bmi‐1, and ABCG2 was detected in all samples of normal and neoplastic odontogenic tissues. Immunohistochemical reactivity for CD133 and Bmi‐1 was evident in odontogenic epithelial cells neighboring the basement membrane in tooth germs, ameloblastomas, and metastasizing ameloblastomas, and ameloblastic carcinomas and clear cell odontogenic carcinomas showed reactivity for CD133 and Bmi‐1 in most neoplastic cells. The level of CD133 immunoreactivity in malignant ameloblastic tumors was significantly higher than the levels in tooth germs and ameloblastomas. Immunoreactivity for ABCG2 in odontogenic epithelial components was detected in some ameloblastic tumors but not in tooth germ tissues. Some granular neoplastic cells in granular cell ameloblastomas showed ABCG2 expression. The level of ABCG2 immunoreactivity in malignant ameloblastic tumors was significantly higher than that in tooth germs. Conclusion: Expression of CD133, Bmi‐1, and ABCG2 in tooth germs and ameloblastic tumors suggests that stem cell‐related molecules might control the maintenance of odontogenic tissues. Expression of these molecules is possibly involved in oncogenesis, cell differentiation, and malignant potential of odontogenic epithelium.